Clinical trials involving KLH. Details such as study status, design and investigators are available by link to outside sites.A Study to Determine the Immunogenicity and Oral Tolerance to Keyhole Limpet Hemocyanin (KLH)
Conditions: Autoimmune Disorders
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID)
Phase 0
December 1, 2011 Healthy, Immune Disease - Autoimmune mRNA-transfected Dendritic Cell Vaccination in High Risk Uveal Melanoma Patients
Conditions: Uveal Melanoma
Sponsors: Radboud University Nijmegen Medical Centre
Phase n/a
April 14, 2009 Cancer - Melanoma Vaccine Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
Conditions: Brain and Central Nervous System Tumors
Sponsors: Duke University, National Institute of Neurological Disorders and Stroke
Phase II
March 25, 2008 | 3 References Cancer - Brain & CNS Condition: Renal Transplant
Sponsors: Hoffman-La Roche Inc.
Phase: IV
April 6, 2007 Transplant Carcinoembryonic Antigen-loaded Dendritic Cells in Advanced Colorectal Cancer Patients
Conditions: Colorectal Cancer, Liver Metastases
Sponsors: Radboud University
Phase I, II
September 27, 2005 | 5 References Cancer - Colon, Cancer - Liver Immune Dysregulation in Children and Adults With Asthma
Conditions: Asthma, Lung Diseases
Sponsors: National Heart, Lung, and Blood Institute (NHLBI)
Phase n/a
August 23, 2005 Asthma Using the Drug Thalidomide to Stimulate T Cells in HIV-Infected People
Conditions: HIV Infections
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID)
Phase II
January 29, 2003 | 3 References HIV, Immune Disease - Secondary